The Gold Standard in Lyme Disease Testing

Issue #38 of “What’s Her Problem?”: When finances drive our medical decision-making, patients may miss out on receiving the best possible care.

May is Lyme Awareness Month!

There’s good news and there’s bad news. I usually give people the bad news first, but with you, I’m going to start with the good news, which is that 90% of this test has come back negative.

The bad news is that you did test positive for long-term Lyme.

My Functional Medicine physician spoke those words to me in October 2022 during a telehealth appointment. Recognizing the pivotal nature of what she said, I documented the precise way she said it....

This week’s questions:

Have you ever said no to a test that might have been diagnostically helpful due to the cost? Or been given a test that is known to be less accurate than another option?

Related Posts:

https://whatsherproblem.substack.com/p/interview-series-dr-wendie-trubow?r=heamx

https://whatsherproblem.substack.com/p/what-if-there-had-been-another-treatment?r=heamx

https://whatsherproblem.substack.com/p/my-heart-disease-has-copycats?r=heamx

Links/References:

https://www.cdc.gov/lyme/hcp/diagnosis-testing/index.html

https://www.cdc.gov/lyme/hcp/diagnosis-testing/index.html

https://www.lymedisease.org/lyme-biobank-study/

https://www.lymedisease.org/mylymedata-clinician-lyme-survey-report/

https://igenex.com/the-igenex-advantage/

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit whatsherproblem.substack.com/subscribe